Gastric Cancer

Early-Onset Gastric Cancer Suggested to be Genetically and Clinically Distinct

January 20, 2020

Incidence of early-onset gastric cancer has steadily increased in the US, now comprising >30% of new gastric cancer cases today, causing researchers to try and discover what makes this disease type unique.

Combo Therapy Shows Modest Survival Gain, More Toxicity for Gastric Cancer

October 22, 2019

A combination of trifluridine and tipiracil showed some gains in overall survival for patients with metastatic gastric cancer or gastroesophageal junction cancer.

TAS-102 Prolongs Survival in Metastatic Gastric, GEJ Adenocarcinoma

October 15, 2019

TAS-102 improved overall survival, compared with placebo, in patients with metastatic gastric or gastroesophageal junction (GEJ) cancer.